title: Surrogate matrix: opportunities and challenges for tissue sample analysis.
abstract: Often there is limited availability of matching tissue matrix and/or the analyte may occur endogenously in the target tissue. Surrogate matrix provides an option for quantitation of drug, metabolite(s) and biomarker(s) in these circumstances. However, the use of a surrogate matrix also presents challenges. This paper summarizes and discusses the challenges of selecting a proper surrogate, validating the suitability of the surrogate and establishing a surrogate tissue method using the fit-for-purpose approach. This paper also systematically reviews the current practices for evaluating key parameters of a surrogate tissue assay, including sensitivity, specificity, selectivity, interference, precision, accuracy, recovery, matrix effects and stability. Considerations and suggestions are provided for dealing with such challenges during method establishment and tissue sample analysis.
authors.affiliation: Drug Metabolism & Pharmacokinetics, Disposition, Safety & Animal Research (DSAR), Sanofi, 153 Second Avenue, Waltham, MA 02451, USA.
authors.forename: Stacy
authors.initials: S
authors.lastname: Ho
authors.affiliation: Drug Metabolism & Pharmacokinetics, Vertex Pharmaceuticals Inc., 50 Northern Avenue, Boston, MA 02210, USA.
authors.forename: Hong
authors.initials: H
authors.lastname: Gao